As of Jul 25, 2024, the Edwards Lifesciences stock's PE ratio is 25.62. This takes into account the latest EPS of $2.33 and stock price of $59.7. The PE ratio marks a decrease of 29% from its last 4 quarters average of 36.3.
The PE ratio of Edwards Lifesciences has averaged 41.5 over the last ten years. The current P/E ratio of 25.62 is 38% lower than the historical average. Looking back at the last ten years, EW's PE ratio peaked in the Dec 2020 quarter at 69.11, when the price was $91.23 and the EPS was $1.32. The lowest point was in the Sep 2014 quarter, when it reached 13.95 with a price of $17.03 and an EPS of $1.22.
Maximum annual increase: 104.49% in 2015
Maximum annual decrease: -43.58% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 33.01 | 8.84% |
| 2022 | 30.33 | -43.58% |
| 2021 | 53.76 | -22.21% |
| 2020 | 69.11 | 49.3% |
| 2019 | 46.29 | 4.26% |
| 2018 | 44.4 | 8.72% |
| 2017 | 40.84 | 16.39% |
| 2016 | 35.09 | 2.63% |
| 2015 | 34.19 | 104.49% |
| 2014 | 16.72 | -11.53% |
Currently, EW's PE ratio is lower than its 3, 5 and 10-year averages.
EW's PE ratio stands lower than its peer stocks BSX and MDT. Edwards Lifesciences is currently trading at a lower PE ratio (25.62) than its peers average of 48.65.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EW Edwards Lifesciences Corp | 26.77 | $37.55B |
| MDT Medtronic plc | 28.41 | $100.91B |
| MMSI Merit Medical Systems Inc | 48.27 | $4.96B |
| LMAT Lemaitre Vascular Inc | 55.97 | $1.92B |
| BSX Boston Scientific Corp | 62.43 | $110.15B |
| ICUI Icu Medical Inc | N/A | $3.12B |
The price to earnings ratio for EW stock as of Jul 25, 2024, stands at 25.62.
The 3-year average price to earnings ratio for EW stock is 39.52.
The 5-year average price to earnings ratio for EW stock is 45.88.
The highest quarterly PE ratio in the last ten years has been 69.11 and it was in the Dec 2020 quarter.
EW's price to earnings ratio is currently 38% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 25, 2024), Edwards Lifesciences's share price is $59.7. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.33. Therefore, Edwards Lifesciences's PE ratio for today is 25.62. PE RATIO(25.62) = STOCK PRICE($59.7) / TTM EPS($2.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.